Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study

Hypertension

Volumn 56, Issue 1, 2010, Pages 44-48

  Nelson, Mark R ^a   Ryan, Philip ^b   Tonkin, Andrew M ^c   Ramsay, Emmae ^b   Willson, Kristyn ^b   Wing, Lindon W H ^e   Reid, Christopher M ^d  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

Aged; Algorithms; Cardiovascular diseases; Hypertension; Risk assessment

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; AUSTRALIA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STROKE; AGE; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MORBIDITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TASMANIA;

EID: 77953807179     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.148007     Document Type: Article

References (32)

1. Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. The Lancet. 2005; 365:217-223.
2. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, Awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and Older. J Gerontol A Biol Sci Med Sci. 2009;64A:256-263.
3. MacMahon SPR, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part 1, Prolonged differences in blood pressure-prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
4. National Vascular Disease Prevention Alliance. Technical Report: Review of the Evidence and Evidence-Based Recommendations for Practice. National Vascular Disease Prevention Alliance; 2009.
5. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, and National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)
7. British Cardiac Society British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, and the Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005;91(suppl 5):v1-v52.
8. National Heart Foundation of Australia, National Blood Pressure and Vascular Disease Advisory Committee. Guide to Management of Hypertension 2008.
9. New Zealand Guidelines Group. The Assessment and Management of Cardiovascular Risk. Wellington, New Zealand; 2003.
10. National Vascular Disease Alliance. Guidelines for the Assessment of Absolute Cardiovascular Disease Risk. 2009
11. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003; 24:1601-1610.
12. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753.
13. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1 part 2):293-298.
14. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel J-P. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001;323:75-81.
15. Simons LA, Simons J, Friedlander Y, McCallum J, Palaniappan L. Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study. Med J Aust. 2003;178:113-116.
16. Simons LA, McCallum J, Friedlander Y, Simons J, Powell I, Heller R. Dubbo study of the elderly: sociological and cardiovascular risk factors at entry. Aust N Z J Med. 1991;21:701-709.
17. Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348: 583-592.
18. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate Glomerular Filtration Rate from serum creatinine: a new prediction equation. Ann Int Med. 1999;130:461-470.
19. Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
20. Steyerberg EW, Borsboom GJ, van Houwelingen HC, Eijkemans MJ, Habbema J, Dik F. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med. 2004;23:2567-2586.
21. Davis WA, Colagiuri S, Davis TME. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust. 2009;190:180-184.
22. Brown M, Palmer C, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366-372. (Pubitemid 30487492)
23. Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Mancia G, de Leeuw PW, Ruilope LM, Rosenthal T, Chatellier G, for the Intervention as a Goal in Hypertension Treatment Study Group. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens. 2002;20:1973-1980.
24. Stork S, Feelders RA, van den Beld AW, Steyerberg EW, Savelkoul HF, Lamberts SW, Grobbee DE, Bots ML. Prediction of mortality risk in the elderly. Am J Med. 2006;119:519-525.
25. de Ruijter W, Westendorp RGJ, Assendelft WJJ, den Eizen WPJ, de Craen AJM, le Cessie S, Gussekloo J. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083.
26. Whisnant JP. Modeling of risk factors for ischemic stroke: the Willis Lecture. Stroke. 1997;28:1840-1844.
27. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639.
28. Woodward M, Brindle P, Tunstall-Pedoe H, for the Sign Group on Risk Estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172-176
29. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197-208.
30. May M, Lawlor DA, Brindle P, Patel R, Ebrahim S. Cardiovascular disease risk assessment in older women: can we improve on Fra-mingham? British Women's Heart and Health Prospective Cohort Study. Heart. 2006;92:1396-1401.
31. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the Elderly. Arterioscler Throm VascBiol. 1997; 17:1121-1127.
32. Cao JJ, Biggs ML, Barzilay J, Konen J, Psaty BM, Kuller L, Bleyer AJ, Olson J, Wexler J, Summerson J, Cushman M. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study. Atherosclerosis. 2008; 197:806-813.